COLUMBIA, Md., Feb. 22 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation today announced that it will make available its upcoming quarterly conference call with investors live via the Internet on Tuesday, March 7, 2006 at 4:45 p.m. Eastern Time.
The conference call will be hosted via Martek’s regular teleconferencing vendor. In addition to the Company’s standard conference call format, audio for the call will be streamed live over the Internet so that interested investors will be able to listen to the conference call from their desktop computers. The call is expected to be approximately one hour in duration.
Investors who are interested in listening to the call via the Internet may do so by logging onto Martek’s web site at http://www.martekbio.com, selecting the Investors tab, choosing “Live Webcast” and then following the related instructions.
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a plant source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults
Investor Relations (410) 740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations of Martek BiosciencesCorporation, +1-410-740-0081
Web site: http://www.martekbio.com/
